NCT06278493View on ClinicalTrials.gov

A Clinical Study of AL2846 Capsule Combined With Gemzar Injection in the Treatment of Advanced Pancreatic Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

August 23, 2018

Primary Completion Date

October 25, 2021

Study Completion Date

May 1, 2023

Conditions
Pancreatic Cancer
Interventions
DRUG

AL2846 capsules

AL2846 is a multi -target receptor tyrosine kinase inhibitor.

DRUG

Gemzar

It is a chemotherapeutic drug.

Trial Locations (1)

300181

Tianjin Medical University Cancer Hospital, Tianjin

Sponsors
All Listed Sponsors
lead

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

INDUSTRY